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1. INTRODUCTION {#mbo3960-sec-0001}
===============

The amino acid serine is a centrally important biomolecule, not only as a substrate for protein synthesis but also as a precursor of nucleotides, redox molecules, phospholipids, and other amino acids (Locasale, [2013](#mbo3960-bib-0020){ref-type="ref"}; Stauffer, [2004](#mbo3960-bib-0039){ref-type="ref"}). While the biochemical reactions involved in serine metabolism are well known, understanding of how cells regulate fluxes and intracellular concentrations of serine‐associated metabolites remains incomplete. Recent revelations that serine biosynthesis genes are amplified or up‐regulated in many cancers (Liao et al., [2016](#mbo3960-bib-0018){ref-type="ref"}; Locasale et al., [2011](#mbo3960-bib-0021){ref-type="ref"}; Mattaini, Sullivan, & Heiden, [2016](#mbo3960-bib-0024){ref-type="ref"}; Possemato, [2011](#mbo3960-bib-0033){ref-type="ref"}) and required for host colonization by bacterial pathogens (Gao et al., [2017](#mbo3960-bib-0009){ref-type="ref"}; Yasuda et al., [2017](#mbo3960-bib-0046){ref-type="ref"}) has led to renewed interest in elucidating the fundamental principles governing serine metabolism in all cells.

When exogenous serine is available, proliferating bacterial and mammalian cells deplete it rapidly, far faster than any other amino acid (Hosios et al., [2016](#mbo3960-bib-0014){ref-type="ref"}; Selvarasu, [2009](#mbo3960-bib-0036){ref-type="ref"}; Zhang, El‐Hajj, & Newman, [2010](#mbo3960-bib-0047){ref-type="ref"}). This observation has been cited as evidence that replicating cells require large amounts of serine to generate biomass and functional metabolites such as one‐carbon units (Locasale, [2013](#mbo3960-bib-0020){ref-type="ref"}; Newman & Maddocks, [2017](#mbo3960-bib-0027){ref-type="ref"}). However, bacteria deaminate the majority of exogenous serine to produce pyruvate and ammonia (Netzer, Peters‐Wendisch, Eggeling, & Sahm, [2004](#mbo3960-bib-0026){ref-type="ref"}; Ramotar & Newman, [1986](#mbo3960-bib-0034){ref-type="ref"}) (Figure [1](#mbo3960-fig-0001){ref-type="fig"}a), even though this pathway antagonizes growth (Ramotar & Newman, [1986](#mbo3960-bib-0034){ref-type="ref"}) and most pyruvate‐derived carbon is ultimately excreted from the cell (Selvarasu et al., [2009](#mbo3960-bib-0036){ref-type="ref"}). Serine deamination is clearly important because *E. coli* expresses at least one of its three serine deaminase enzymes at all times (Zhang & Newman, [2008](#mbo3960-bib-0048){ref-type="ref"}), yet the metabolic benefits of this reaction remain unclear.

![The role of serine deaminase operons in minimal versus rich media. (a) Schematic of metabolic reactions and relevant enzymes involved in serine biosynthesis and utilization. 3‐PG = 3‐phosphoglycerate. (b) Schematic of the three loci in the *Escherichia coli* genome that encode serine deaminase enzymes. (c) Growth curves of wild‐type and serine deaminase single deletion strains (*sdaA::kan*, ecMK101; *sdaCB*::cm, ecMK102; *tdcG*::cm, ecMK210) grown in minimal medium containing 1.5 mM serine. (d) Growth curves of wild‐type and serine deaminase single deletion strains described in (a) grown in AA‐rich medium containing 5 mM serine. (e) Growth curves of *ΔserA* strains with or without a serine deaminase deletion (*serA*::FRT, ecMK94; *serA*::FRT *sdaA*::kan, ecMK105; *serA*::FRT *sdaCB*::cm, ecMK106; *serA*::FRT *tdcG*::cm, ecMK211) grown in rich medium containing 5 mM serine. For all growth curves, three biological replicates are shown as points with their averages connected by lines. AA‐rich medium refers to a MOPS‐based defined medium containing all amino acids and nucleobases at defined concentrations (Neidhardt et al., [1974](#mbo3960-bib-0025){ref-type="ref"}) (Materials and Methods). In the minimal medium, all amino acids and nucleobases were omitted from the AA‐rich medium except serine](MBO3-9-e960-g001){#mbo3960-fig-0001}

Serine deamination in bacteria is considered a detoxification mechanism because free intracellular serine inhibits biosynthesis of isoleucine and aromatic amino acids (Hama, Sumita, Kakutani, Tsuda, & Tsuchiya, [1990](#mbo3960-bib-0012){ref-type="ref"}; Saito, Ishida, & Yamada, [2003](#mbo3960-bib-0035){ref-type="ref"}). Indeed, all three *E. coli* serine deaminases have *K~m~* values in the millimolar range (Burman, Harris, Hauton, Lawson, & Sawers, [2004](#mbo3960-bib-0004){ref-type="ref"}; Cicchillo, [2004](#mbo3960-bib-0005){ref-type="ref"}), consistent with a role in preventing serine excess (Zhang & Newman, [2008](#mbo3960-bib-0048){ref-type="ref"}). *Escherichia coli* cells unable to deaminate serine become severely elongated in the presence of exogenous serine, suggesting that high serine levels inhibit cell division (Zhang et al., [2010](#mbo3960-bib-0047){ref-type="ref"}; Zhang & Newman, [2008](#mbo3960-bib-0048){ref-type="ref"}). This toxicity may stem from defects in cell wall production given that misincorporation of serine in place of alanine into peptidoglycan crosslinks impairs peptidoglycan biosynthesis (Parveen & Reddy, [2017](#mbo3960-bib-0030){ref-type="ref"}). In all cases documented so far, toxicity occurs in the presence of exogenous serine; whether serine toxicity can occur in the absence of exogenous serine is not known.

Ribosome pausing is consistently observed at serine codons in bacterial ribosome profiling studies (Li, Oh, & Weissman, [2012](#mbo3960-bib-0017){ref-type="ref"}; Martens, Taylor, & Hilser, [2015](#mbo3960-bib-0023){ref-type="ref"}), indicating that intracellular serine concentrations or charging levels of seryl‐tRNAs may be low compared with other amino acids. Surprisingly, the proportion of charged to uncharged seryl‐tRNAs was observed to be much lower in rich media compared to minimal media (where exogenous serine is not available) (Avcilar‐Kucukgoze, [2016](#mbo3960-bib-0002){ref-type="ref"}), suggesting that intracellular serine levels may be lower in nutrient‐rich conditions. Given that known serine toxicities should be less severe when all amino acids are available, the physiological benefits of maintaining low serine levels in rich media are unclear.

Here, we report that *E. coli* cells lacking the *sdaCB* operon, which encodes a serine transporter and a serine deaminase, lyse upon glucose depletion, thus revealing a role for *sdaCB* during adaptation to changes in nutrient availability. Unexpectedly, the serine transporter SdaC has a dominant role over the deaminase SdaB in mediating the observed phenotype. Lysis can be modulated by altering glycine or alanine levels in the growth medium, indicating the importance of maintaining a strict ratio of serine to other amino acids during metabolic shifts. Together, our results reveal that the serine transporter SdaC promotes amino acid homeostasis during adaptation to glucose limitation in *E. coli*.

2. MATERIALS AND METHODS {#mbo3960-sec-0002}
========================

2.1. Growth media {#mbo3960-sec-0003}
-----------------

Bacteria were grown in a MOPS‐based defined medium (Neidhardt, Bloch, & Smith, [1974](#mbo3960-bib-0025){ref-type="ref"}) (adapted from the *E. coli* genome project \[[E. coli Genome Project](#mbo3960-bib-0008){ref-type="ref"}\]), containing 0.5% (28 mM) glucose as the carbon source unless otherwise noted. The 5X Supplement was replaced with a 5X solution containing 4 mM of each amino acid (0.8 mM final concentration) except serine, glycine and alanine, which were added separately. When needed, glycine and alanine were added to a final concentration of 0.8 mM and serine was added to a final concentration of 10 mM, unless otherwise noted. This medium is designated as AA‐rich medium throughout the text. The medium that produces lysis of *ΔsdaC* strains contains 0.025% (1.4 mM) glucose and no serine. For all growth curve experiments in AA‐rich medium, overnight cultures were grown in AA‐rich medium containing 0.5% glucose and 10 mM serine and diluted 1:100 into experimental media. For the minimal medium experiment (Figure [1](#mbo3960-fig-0001){ref-type="fig"}c), nucleobases and amino acids were omitted. Overnight cultures were grown in minimal medium without serine and diluted 1:100 into minimal medium containing 1.5 mM serine. For cloning and strain construction, bacteria were grown in LB medium (BD/Difco) and the antibiotics carbenicillin (100 µg/ml), chloramphenicol (25 µg/ml), or kanamycin (25 µg/ml) were included when required.

2.2. Strain construction {#mbo3960-sec-0004}
------------------------

All experiments were carried out with wild‐type *Escherichia coli* strains BW25113 (Datsenko & Wanner, [2000](#mbo3960-bib-0006){ref-type="ref"}) or MG1655 (Blattner et al., [1997](#mbo3960-bib-0003){ref-type="ref"}) and mutant derivatives constructed using the one‐step gene disruption method (Datsenko & Wanner, [2000](#mbo3960-bib-0006){ref-type="ref"}; Datta, Costantino, & Court, [2006](#mbo3960-bib-0007){ref-type="ref"}) (Table [A1](#mbo3960-tbl-0001){ref-type="table"}). Briefly, an antibiotic resistance cassette was amplified from plasmid pKD13 (kan) or pKD32 (cm) using primers containing gene‐specific 5′ extensions (Table [A2](#mbo3960-tbl-0002){ref-type="table"}). Each cassette was designed to remove the region from the start codon to the stop codon of the gene, or from the *sdaC* start codon to the *sdaB* stop codon in the case of the *sdaCB* deletion (see Table [A2](#mbo3960-tbl-0002){ref-type="table"} for exact flanking sequences). Recombination was achieved by electroporating 500ng of cassette DNA into a strain harboring plasmid pSIM6. pSIM6‐harboring competent cells were prepared following growth to OD~600~ = 0.4--0.5 in LB and heat shock at 42°C for 15 min to induce expression of the *λ*‐Red recombinase machinery (Datta et al., [2006](#mbo3960-bib-0007){ref-type="ref"}). When desired, the antibiotic resistance cassette was excised using pCP20 as described (Datsenko & Wanner, [2000](#mbo3960-bib-0006){ref-type="ref"}), leaving an 84 bp scar sequence that contains stop codons in all six reading frames (denoted as ::FRT in the genotypes listed in Table [A1](#mbo3960-tbl-0001){ref-type="table"}) (Datsenko & Wanner, [2000](#mbo3960-bib-0006){ref-type="ref"}). When making additional mutations in a strain already harboring a cassette or scar sequence, the antibiotic cassette was generated by colony PCR from a strain already containing the insertion using primers approximately 100 bp outside of the insertion. This strategy yields a cassette with longer homology arms and significantly reduced integration of the cassette into the locus of the first mutation. Successful strain construction was confirmed by colony PCR and Sanger sequencing.

2.3. Plasmid construction {#mbo3960-sec-0005}
-------------------------

pASEC1 (Addgene plasmid \#53241), a very low‐copy expression vector (SC\*101 ori, 3--4 copies per cell) used in our previous work (Subramaniam, Pan, & Cluzel, [2013](#mbo3960-bib-0042){ref-type="ref"}), was used as a backbone for constructing the transcriptional reporters shown in Figure [4](#mbo3960-fig-0004){ref-type="fig"}c. For each gene of interest, the promoter region was amplified from genomic DNA using the primers listed in Table [A2](#mbo3960-tbl-0002){ref-type="table"} and inserted between the XhoI and EcoRI sites of pASEC1 via Gibson assembly. This strategy removes the pLtetO‐1 promoter and places the gene‐specific promoter directly upstream of the T7 ribosome binding site and *yfp* coding region. Successful construction was confirmed by colony PCR and Sanger sequencing.

2.4. Growth and fluorescence measurements {#mbo3960-sec-0006}
-----------------------------------------

Bacterial strains were streaked onto LB plates, and single colonies were used to inoculate overnight cultures of AA‐rich medium (with 10 mM serine) in triplicate in standard 96‐well plates (Costar 3595). Cultures were incubated overnight at 37°C with shaking (Titramax 100 shaker, 900 rpm), diluted 1:100 into experimental media, and returned to 37°C with shaking. Cell density (absorbance at 600 nm) and YFP fluorescence (excitation 504 nm and emission 540 nm) were monitored every 40--60 min using a Tecan plate reader (Infinite M1000 PRO). To minimize evaporation, wells on the edge of the plate were filled with water and plates were sealed with parafilm between readings.

2.5. Cell viability assays {#mbo3960-sec-0007}
--------------------------

At the indicated time points, 1 µl of each culture was serially diluted in 1× MOPS. 2 µl of each dilution was spotted onto an LB plate using a multichannel pipettor. Plates were photographed after incubation at 37°C for 18 hr.

2.6. Glucose assays {#mbo3960-sec-0008}
-------------------

Cells were growth in 96‐well plates as described above. At the indicated time points, 900 µl of culture was passed through a 0.22 µm filter using a 1 ml syringe and stored at −20°C until processing. 100 µl of culture supernatant was mixed with 200 µl of glucose assay reagent (Sigma, GAHK20) in a 96‐well plate and incubated at room temperature for 15 min. Absorbance at 340nm was measured using a Tecan plate reader (Infinite M1000 PRO). Sample absorbance was normalized by subtracting the absorbance of 200 µl glucose assay reagent mixed with 100 µl water. Glucose quantities were calculated from a standard curve generated using the kit\'s glucose standard solution.

2.7. Microscopy {#mbo3960-sec-0009}
---------------

Cells harboring pASEC1 were grown in 96‐well plates as described above. At the indicated time points, 3 µl of culture was transferred to a poly‐L‐lysine‐coated microscope slide and covered with a coverslip. Cells were imaged on a DeltaVision Elite microscope at 60× magnification in the bright field and YFP channels. Cell number and cell area were measured using ImageJ software. YFP channel images (which only capture live cells) were converted to 16‐bit grayscale, and the threshold was adjusted to 61--255 to remove background. Cell area was calculated using the Analyze Particles function. Six fields per strain were imaged and quantified at each time point.

2.8. Live--dead staining and imaging {#mbo3960-sec-0010}
------------------------------------

At the indicated time point, 5 µl of culture was mixed with a 1:100 dilution of a 1:1 mix of SYTO9 and propidium iodide from the BacLight Live/Dead bacterial viability kit (L7012, Thermo Fisher). The cells were stained by incubating at room temperature for 15 min and then placed on ice until imaging. 3 µl of the stained cultures were spotted between a coverglass and coverslip. Images were collected on a Leica DMi8 epifluorescence microscope with a 100× magnification oil‐immersion objective in the phase‐contrast, GFP and RFP channels. The images were opened using ImageJ software, and the contrast and brightness were adjusted using the Auto mode. Cells were manually identified using the phase‐contrast image and were then classified as live or dead from the corresponding fluorescence images. Five fields per strain were imaged and quantified at each time point.

2.9. Quantitative PCR {#mbo3960-sec-0011}
---------------------

The 3 ml cultures were grown to mid‐exponential phase in AA‐rich medium (with 5 mM serine) and harvested by centrifugation at 3,000 g for 5 min. Cell pellets were resuspended in 250 µl 0.3 M sodium acetate and 10 mM EDTA (pH 4.5) and mixed with 250 µl acid phenol‐chloroform (pH 4.5) and 250 µl glass beads (G1877, Sigma). Samples were vortexed for 3 min at maximum speed and clarified by centrifugation at 12,000 g for 10 min at 4°C. The aqueous layer was collected, and RNA was purified using the Direct‐zol RNA purification kit (Zymo Research).

The 300 ng purified RNA was treated with DNase I (NEB) for 10 min at 37°C according to the manufacturer\'s instructions. Reverse transcription (RT) was performed using Maxima RT enzyme (EP0741, Thermo Fisher) and random hexamer primers using a 20 µl reaction volume. After incubation at 25°C for 10 min, 50°C for 30 min and 85°C for 5 min, samples were diluted 10‐fold and 2 µl of diluted sample was used as template for a 10 µl qPCR reaction in the next step. qPCR was performed using Maxima SYBR Green/ROX qPCR Master Mix (FERK0221, Thermo Fisher) according to the manufacturer\'s instructions. qPCR was performed in duplicate for each RT reaction using primers listed in Table [A2](#mbo3960-tbl-0002){ref-type="table"}. Negative RT controls were included to confirm the absence of DNA contamination. For each gene, C~T~ values were converted to mRNA quantity by generating a standard curve from genomic DNA. *gapA* mRNA was used as internal reference to normalize all other mRNA levels.

3. RESULTS {#mbo3960-sec-0012}
==========

3.1. Cells lacking *sdaCB* exhibit a growth defect during entry into stationary phase {#mbo3960-sec-0013}
-------------------------------------------------------------------------------------

The *E. coli* genome encodes three separate serine deaminases (Figure [1](#mbo3960-fig-0001){ref-type="fig"}b), of which at least one is always expressed; SdaA predominates in nutrient‐poor conditions, SdaB predominates in nutrient‐rich conditions, and TdcG predominates during anaerobiosis (Shao & Newman, [1993](#mbo3960-bib-0038){ref-type="ref"}; Zhang & Newman, [2008](#mbo3960-bib-0048){ref-type="ref"}). SdaB is coexpressed with the predicted serine transporter SdaC (Shao, Lin, & Newman, [1994](#mbo3960-bib-0037){ref-type="ref"}), but the functional interplay between these two proteins is unknown. To investigate the role of serine deamination in different growth conditions, we constructed strains of *E. coli* (BW25113) harboring deletions of *sdaA*, *sdaCB* or *tdcG* (Figure [1](#mbo3960-fig-0001){ref-type="fig"}b, Table [A1](#mbo3960-tbl-0001){ref-type="table"}). \[Note: for all strains mentioned in the text and figures, Δ indicates replacement of the gene\'s coding sequence by a kanamycin resistance cassette (kan), chloramphenicol resistance cassette (cm), or FRT scar sequence as described in Materials and Methods and as indicated in Table [A1](#mbo3960-tbl-0001){ref-type="table"} and figure legends.\] *E. coli* grown in minimal media containing serine require *sdaA* for survival (Su, Lang, & Newman, [1989](#mbo3960-bib-0040){ref-type="ref"}; Su & Newman, [1991](#mbo3960-bib-0041){ref-type="ref"}) because free serine inhibits the biosynthesis of some other amino acids (Hama et al., [1990](#mbo3960-bib-0012){ref-type="ref"}; Saito et al., [2003](#mbo3960-bib-0035){ref-type="ref"}). We confirmed that our *ΔsdaA* strain is unable to grow in MOPS minimal medium containing serine (Figure [1](#mbo3960-fig-0001){ref-type="fig"}c). Under the same conditions, deletion of the *sdaCB* or *tdcG* genes did not negatively impact growth (Figure [1](#mbo3960-fig-0001){ref-type="fig"}c), consistent with reports that these genes are not highly expressed in minimal media (Su & Newman, [1991](#mbo3960-bib-0041){ref-type="ref"}).

To investigate the role of serine deamination in nutrient‐rich conditions, we monitored the growth of wild‐type and the three serine deaminase single mutant strains in a MOPS‐buffered defined medium supplemented with all amino acids and nucleobases (Neidhardt et al., [1974](#mbo3960-bib-0025){ref-type="ref"}) (henceforth referred to as AA‐rich medium). All four strains exhibited identical growth kinetics until they began transitioning to stationary phase, at which point the optical density (OD) of the *ΔsdaCB* strain stopped increasing, resulting in a slight defect in overall growth yield (Figure [1](#mbo3960-fig-0001){ref-type="fig"}d). This result suggested to us that *sdaCB* is not required for exponential growth in the presence of serine in AA‐rich medium but may become beneficial when specific nutrients are depleted. The growth yield defect of *ΔsdaCB* cells was smaller in a medium containing glycerol, rather than glucose, as the carbon source (Figure [A1](#mbo3960-fig-0006){ref-type="fig"}, panel a), suggesting that the effect may be glucose‐specific.

To estimate the effect of SdaC and SdaB activity on growth in AA‐rich medium, we performed the same experiment described above in a *ΔserA* background, in which cells are unable to synthesize serine de novo and growth yield is thus proportional to the availability of exogenous serine for biomass production. Indeed, growth of the *ΔserA* strain stopped abruptly after three hours (Figure [1](#mbo3960-fig-0001){ref-type="fig"}e) and could be rescued by readdition of 5 mM serine (Figure [A1](#mbo3960-fig-0006){ref-type="fig"}, panel b), indicating that exogenous serine becomes depleted by mid exponential phase in our AA‐rich medium. If any of the serine deaminases are highly active in our experimental growth condition, then we expect the corresponding serine biosynthesis‐deaminase double mutant strains (Table [A1](#mbo3960-tbl-0001){ref-type="table"}) to have higher growth yield than the *ΔserA* single mutant because serine is not being converted to pyruvate and subsequently excreted from the cell as acetate. While the growth yield of the *ΔserA ΔsdaA* and *ΔserA ΔtdcG* strains was the same as the *ΔserA* strain, the *ΔserA ΔsdaCB* strain had a dramatically higher growth yield (Figure [1](#mbo3960-fig-0001){ref-type="fig"}e), suggesting that SdaC/B activity competes with reactions that convert serine into biomass and consumes a significant amount of exogenous serine. Together, these results indicate that the *sdaCB* operon is highly active during growth in AA‐rich medium despite antagonizing biomass production and may benefit cells as they transition to nutrient deprivation.

3.2. Cells lacking *sdaCB* lyse upon glucose depletion {#mbo3960-sec-0014}
------------------------------------------------------

Because we observed a mild growth defect for the *ΔsdaCB* strain during entry into stationary phase in glucose‐containing AA‐rich medium, we hypothesized that *sdaCB* might aid cells in making the metabolic changes necessary to adapt when glucose is exhausted. To test this idea, we compared the growth of wild‐type and *ΔsdaCB* cells in modified AA‐rich medium in which availability of glucose was limited. In medium containing 1.4 mM glucose (20‐fold lower concentration than normal) and lacking serine, wild‐type cells grew normally to a final OD~600~ that was approximately 2.5‐fold lower than in AA‐rich medium (Figure [2](#mbo3960-fig-0002){ref-type="fig"}a). In the same low‐glucose medium, the *ΔsdaCB* strain grew similarly to the wild‐type until approximately 150 min, at which point its optical density began decreasing, eventually dropping to background levels (Figure [2](#mbo3960-fig-0002){ref-type="fig"}a). This phenotype was observed only when both glucose and serine were limiting; addition of either 5.6 mM glucose or 3 mM serine restored growth to wild‐type levels (Figure [A2](#mbo3960-fig-0007){ref-type="fig"}, panel a). Lysis of *ΔsdaCB* cells was also observed in a different *E. coli* genetic background (MG1655, Table [A1](#mbo3960-tbl-0001){ref-type="table"}), indicating that the phenotype is not strain‐specific (Figure [A2](#mbo3960-fig-0007){ref-type="fig"}, panel b).

![*sdaCB* prevents lysis upon glucose depletion. (a) Growth curves of wild‐type and *ΔsdaCB* (*sdaCB*::cm, ecMK102) strains in AA‐rich medium containing 0.025% (1.4 mM) glucose and no serine. (b) Bright‐field microscopy images of wild‐type and *ΔsdaCB* cells (*sdaCB*::cm, ecMK102; 60× magnification) grown as in (a) and transferred to poly‐L‐lysine‐coated microscope slides at the indicated time points. (c) Individual cell areas measured as described in Materials and Methods for wild‐type (*n* = 206, 150 min; *n* = 286, 180 min) and *ΔsdaCB* (*sdaCB*::cm, ecMK102; *n* = 316, 150 min; *n* = 50, 180 min) strains grown as in (a). (d) Colony‐forming unit (CFU) assays performed in biological triplicate at the indicated time points for cells grown in AA‐rich medium containing 0.025% (1.4 mM) glucose and no serine. 2 µl of each serial dilution was spotted onto an LB plate. (e) Live--dead staining of wild‐type and *ΔsdaCB* cells (*sdaCB*::cm, ecMK102; 100× magnification) grown as in (a) at the 150 min time point. Cells were stained and imaged by fluorescence microscopy as described in Materials and Methods. For each strain, two representative fields of view in the green (live) and red (dead) channels are shown out of the five fields of view that were quantified. 3% of wild‐type cells (one out of 39) and 43% of *ΔsdaCB* cells (17 out of 40) stained red and were classified as dead. (f) Glucose levels in sterile medium (1.4 mM glucose, no serine, blue points) and in culture supernatants at the indicated time points. Biological duplicates representative of three independent experiments are shown. (g) Growth curves of wild‐type and *ΔsdaCB* strains following removal of glucose. Overnight cultures were diluted 1:100 into AA‐rich medium with 2.8 mM glucose and no serine for 105 min. The cultures were then spun down briefly to remove the media, and cells were resuspended in AA‐rich medium with no glucose or serine prior to measurement of optical density over time. For all growth curves, three biological replicates are shown as points with their averages connected by lines](MBO3-9-e960-g002){#mbo3960-fig-0002}

A downward trend in optical density is often indicative of cell lysis. Using microscopy, we observed fewer intact cells and accumulation of cellular debris for *ΔsdaCB* cells, but not wild‐type cells, after 150 min (Figure [2](#mbo3960-fig-0002){ref-type="fig"}b). Interestingly, lysis was not preceded by significant morphological changes (Figure [2](#mbo3960-fig-0002){ref-type="fig"}b), as has been observed in other studies of serine deaminase mutants (Zhang et al., [2010](#mbo3960-bib-0047){ref-type="ref"}; Zhang & Newman, [2008](#mbo3960-bib-0048){ref-type="ref"}). We did observe a decrease in cell size for the wild‐type strain (Figure [2](#mbo3960-fig-0002){ref-type="fig"}c), which is expected for entry into stationary phase (Kolter, Siegele, & Tormo, [1993](#mbo3960-bib-0015){ref-type="ref"}). By contrast, *ΔsdaCB* cells did not become smaller over time (Figure [2](#mbo3960-fig-0002){ref-type="fig"}c), suggesting either that they failed to adapt to changing nutrient availability or that those *ΔsdaCB* cells that did shrink also lysed. To confirm that the drop in OD coincides with a loss of viability, we plated serial dilutions of wild‐type and *ΔsdaCB* cultures on LB plates, and observed that after 150--240 min, the *ΔsdaCB* cultures yielded approximately 100‐fold fewer colony‐forming units (CFU) than the wild‐type strain (Figure [2](#mbo3960-fig-0002){ref-type="fig"}d). In addition, live/dead staining of bacteria at 150 min revealed that 43% of *ΔsdaCB* cells were dead at this time point (*n* = 40 cells), whereas only 3% of wild‐type cells were dead (*n* = 39 cells) (Figure [2](#mbo3960-fig-0002){ref-type="fig"}e).

The lysis phenotype did not occur when glucose was replaced by the alternative carbon sources glycerol or pyruvate (Figure [A2](#mbo3960-fig-0007){ref-type="fig"}, panel c), suggesting a specific role for glucose depletion in causing lysis of *ΔsdaCB* cells. To determine whether the timing of lysis coincides with glucose depletion, we measured glucose levels in culture supernatants over time. We found that glucose levels dropped below detectable concentrations by 160 min, which corresponds with the time at which *ΔsdaCB* cells begin lysing (Figure [2](#mbo3960-fig-0002){ref-type="fig"}f, Figure [A2](#mbo3960-fig-0007){ref-type="fig"}, panel d). To further test whether glucose depletion is the trigger for lysis of the *ΔsdaCB* strain, we grew cells in AA‐rich medium containing 2.8 mM glucose and no serine for 100 min and then switched them to the same medium containing no glucose. As predicted, the medium switch caused complete lysis of the *ΔsdaCB* strain, but not the wild‐type strain (Figure [2](#mbo3960-fig-0002){ref-type="fig"}g). This result supports the conclusion that *ΔsdaCB* cells lyse specifically upon glucose depletion in the absence of exogenous serine.

3.3. *sdaC* is sufficient to prevent lysis {#mbo3960-sec-0015}
------------------------------------------

To gain insight into the mechanism by which loss of *sdaCB* causes lysis, we constructed *sdaC* and *sdaB* single deletion strains (Table [A1](#mbo3960-tbl-0001){ref-type="table"}). To minimize polar effects of removing *sdaC* on expression of *sdaB*, we excised the antibiotic cassette from the *sdaC* deletion strain using pCP20 (Datsenko & Wanner, [2000](#mbo3960-bib-0006){ref-type="ref"}). This approach leaves an 84 bp scar sequence in place of the *sdaC* coding region that contains stop codons in all six reading frames (Datsenko & Wanner, [2000](#mbo3960-bib-0006){ref-type="ref"}). We next measured the individual effects of *sdaC* and *sdaB* deletions on the lysis phenotype in medium with low glucose and no serine. Unexpectedly, the serine deaminase mutant, *ΔsdaB*, did not lyse upon glucose depletion, whereas the serine transporter mutant, *ΔsdaC*, did lyse (Figure [3](#mbo3960-fig-0003){ref-type="fig"}a). qRT‐PCR analysis revealed that deletion of *sdaC* reduces *sdaB* expression (Figure [A3](#mbo3960-fig-0008){ref-type="fig"}, panel a) despite removal of the antibiotic cassette. To confirm that lysis of *ΔsdaC* cells was caused by loss of *sdaC* alone, rather than polar effects on expression of *sdaB*, we tested whether low‐copy plasmids (pSC\*101 *ori*, 3--4 copies/cell, Table [A1](#mbo3960-tbl-0001){ref-type="table"}) (Lutz & Bujard, [1997](#mbo3960-bib-0022){ref-type="ref"}) expressing *sdaC* or *sdaB* alone could prevent lysis. A plasmid expressing *sdaC* under the control of its native promoter completely rescued lysis of the *ΔsdaCB* strain (Figure [3](#mbo3960-fig-0003){ref-type="fig"}b), whereas *ΔsdaCB* cells still lysed when harboring a plasmid expressing *sdaB* under the control of the *sdaCB* promoter (Figure [3](#mbo3960-fig-0003){ref-type="fig"}b). Together, these results indicate that *sdaC* expression is sufficient to prevent lysis, regardless of whether *sdaB* is present (Figure [3](#mbo3960-fig-0003){ref-type="fig"}b).

![*sdaC* is sufficient to prevent lysis and antagonizes biomass production. (a) Growth curves of wild‐type, *ΔsdaC* (*sdaC*::FRT, ecMK180), *ΔsdaB* (*sdaB*::kan, ecMK163), and *ΔsdaCB* (*sdaCB*::cm, ecMK102) strains in AA‐rich medium with 1.4 mM glucose and no serine. (b) Growth curves of wild‐type and *ΔsdaCB* strains harboring a low‐copy plasmid expressing *yfp* (vector; ecMK136,141) or derivatives expressing *sdaC* under the control of its native promoter and leader sequence (sdaC; ecMK184,185), *sdaB* under the control of its native promoter (sdaB‐native; ecMK194,195) or *sdaB* under the control of the strong promoter pLtetO‐1 (sdaB‐high; ecMK187,188) (Table [A1](#mbo3960-tbl-0001){ref-type="table"}). Cells were grown in the same medium as in (a). (c) Growth curves of *ΔserA* strains with or without deletion of *sdaB* and/or *sdaC* (ecMK94, 106, 164, 181) in AA‐rich medium containing 5 mM serine. (d) Growth curves of *ΔserA* and *ΔserA ΔsdaCB* strains harboring a low‐copy plasmid expressing *yfp* (vector; ecMK140,142) or derivatives expressing *sdaC* under the control of its native promoter and leader sequence (sdaC; ecMK197, 198) or *sdaB* under the control of its native promoter (sdaB‐native; ecMK200, 201). Cells were grown in the same medium as in (c). For all growth curves, three biological replicates are shown as points with their averages connected by lines](MBO3-9-e960-g003){#mbo3960-fig-0003}

Interestingly, a plasmid overexpressing *sdaB* under the control of the highly active pLtetO‐1 promoter (Table [A1](#mbo3960-tbl-0001){ref-type="table"}) (Lutz & Bujard, [1997](#mbo3960-bib-0022){ref-type="ref"}) did prevent lysis of the *ΔsdaCB* strain (Figure [3](#mbo3960-fig-0003){ref-type="fig"}b), indicating that overexpression of *sdaB* can substitute for loss of *sdaC*. To rule out the possibility that insufficiency of the *ΔsdaB* mutation to cause lysis is due to compensatory induction of another serine deaminase, we constructed a *ΔsdaB ΔsdaA ΔtdcG* triple deletion strain (Table [A1](#mbo3960-tbl-0001){ref-type="table"}); this strain also did not lyse upon glucose depletion (Figure [A3](#mbo3960-fig-0008){ref-type="fig"}, panel b). Finally, to rule out the possibility that a genetic determinant other than the *sdaC* coding region is responsible for preventing lysis, we constructed a derivative of the *sdaC*‐expressing plasmid containing a point mutation that introduces a premature stop codon after the 82nd amino acid of *sdaC*. This plasmid was unable to prevent lysis of *ΔsdaCB* cells (Figure [A3](#mbo3960-fig-0008){ref-type="fig"}, panel c).

To assess the effect of *sdaC* expression on biomass production, we returned to the *ΔserA* strain background that requires exogenously provided serine for normal growth yield. We observed that deletion of *sdaC* alone dramatically increased growth yield in the *ΔserA* background in AA‐rich medium, whereas deletion of *sdaB* alone only slightly increased yield (Figure [3](#mbo3960-fig-0003){ref-type="fig"}c). To confirm that *sdaC* expression is sufficient to suppress growth, we performed the same experiment in strains harboring plasmids that express *sdaC* or *sdaB* from the *sdaCB* promoter, or the parent vector that constitutively expresses *yfp* (Table [A1](#mbo3960-tbl-0001){ref-type="table"}). The *sdaC*‐expressing plasmid reduced the growth yield of the *ΔserA ΔsdaCB* strain, whereas the vector and *sdaB*‐expressing plasmid had no effect (Figure [3](#mbo3960-fig-0003){ref-type="fig"}d). These results indicate that *sdaC* expression significantly reduces growth yield in a strain unable to synthesize serine de novo--independently of *sdaB*, suggesting that SdaC diverts serine away from biomass production.

3.4. The glycine cleavage system promotes lysis upon glucose depletion {#mbo3960-sec-0016}
----------------------------------------------------------------------

De novo serine biosynthesis begins with the glycolytic intermediate 3‐phosphoglycerate, which is converted to serine via three steps (Mattaini et al., [2016](#mbo3960-bib-0024){ref-type="ref"}; Pizer, [1963](#mbo3960-bib-0032){ref-type="ref"}; Stauffer, [2004](#mbo3960-bib-0039){ref-type="ref"}) (Figure [1](#mbo3960-fig-0001){ref-type="fig"}a). Because lysis of the *ΔsdaC* strain occurs when cells cannot obtain serine from the growth medium and have run out of its biosynthetic precursor (glucose), we reasoned that lysis may coincide with induction of alternative pathways for serine production (Figure [4](#mbo3960-fig-0004){ref-type="fig"}a). The primary means of generating serine besides de novo synthesis is to catabolize other amino acids, such as glycine or threonine (Stauffer, [2004](#mbo3960-bib-0039){ref-type="ref"}); thus, it could be that amino acid catabolism contributes to the lysis phenotype. In accordance with this hypothesis, the *ΔsdaC* strain did not lyse when glycine was omitted from the lysis‐promoting growth medium (1.4 mM glucose, no serine; Figure [4](#mbo3960-fig-0004){ref-type="fig"}b).

![The glycine cleavage system promotes lysis upon glucose depletion. (a) Schematic of metabolic pathways involved in serine production. (b) Growth curves of wild‐type and *ΔsdaC* (*sdaC*::FRT, ecMK180) strains in AA‐rich medium with 1.4 mM glucose, no serine, and no glycine. (c) Relative YFP fluorescence (glucose‐depleted vs. glucose‐containing media) from wild‐type strains harboring transcriptional reporters for genes related to glycine and threonine catabolism (ecMK136, 137, 147, 172, 174, 176, 178). Raw fluorescence values were first normalized to culture OD, and relative fluorescence was calculated by dividing the YFP/OD signal (averaged over the three time points directly after glucose depletion occurs in the 1.4 mM glucose condition) from cells grown in media containing 1.4 mM versus 5.6 mM glucose. (d) Growth curves of wild‐type, *ΔgcvP* (*gcvP*::kan, ecMK129), *ΔsdaC* (*sdaC*::FRT, ecMK180), and *ΔgcvP ΔsdaC* (*gcvP*::cm *sdaC*::FRT, ecMK196) strains in AA‐rich medium with 1.4 mM glucose and no serine. For all growth curves, three biological replicates are shown as points with their averages connected by lines. For YFP induction, average and standard error over biological triplicates is shown](MBO3-9-e960-g004){#mbo3960-fig-0004}

In order to determine which biochemical pathway(s) involved in serine production might become more active upon glucose depletion, we constructed transcriptional reporters for operons known to be involved in generating serine from other amino acids: the glycine cleavage system (*gcvTHP*), serine hydroxymethyltransferase (*glyA*), threonine dehydrogenase (*kbl‐tdh*), and threonine aldolase (*ltaE*) (Figure [4](#mbo3960-fig-0004){ref-type="fig"}a). As controls, we also constructed transcriptional reporters for the serine deaminase operon *sdaCB* and the serine biosynthesis gene *serA*. Promoters of interest were cloned upstream of the *yfp* translation initiation signals (RBS) and coding region in a low‐copy plasmid (Figure [4](#mbo3960-fig-0004){ref-type="fig"}c, Table [A1](#mbo3960-tbl-0001){ref-type="table"}). We measured YFP levels over time in wild‐type strains harboring each reporter in two conditions: the lysis‐promoting medium (1.4 mM glucose, no serine) or the same medium containing additional glucose (5.6 mM). We compared YFP production from a given reporter over the time range at which *ΔsdaC* cells lyse in the low‐glucose condition (Figure [4](#mbo3960-fig-0004){ref-type="fig"}c); cells grown in the higher glucose condition have not yet depleted the glucose supply by this time. The only amino acid catabolic operon that showed transcriptional induction upon glucose depletion was *gcvTHP* (Figure [4](#mbo3960-fig-0004){ref-type="fig"}c), which encodes enzymes that extract a methyl group from glycine. This methyl group can then be combined with an additional glycine molecule by GlyA to produce serine (Stauffer, [2004](#mbo3960-bib-0039){ref-type="ref"}). Of note, we also observed induction of *sdaCB* itself, consistent with the known regulation of this operon by catabolite repression (Hollands, Busby, & Lloyd, [2007](#mbo3960-bib-0013){ref-type="ref"}) (Figure [4](#mbo3960-fig-0004){ref-type="fig"}c).

Based on the role of glycine in promoting lysis (Figure [2](#mbo3960-fig-0002){ref-type="fig"}a vs. Figure [4](#mbo3960-fig-0004){ref-type="fig"}b) and the modest transcriptional activation of the glycine cleavage operon upon glucose depletion (Figure [4](#mbo3960-fig-0004){ref-type="fig"}c), we hypothesized that glycine cleavage by GcvTHP contributes to lysis of the *ΔsdaC* strain. To test this idea, we deleted the *gcvP* gene, encoding glycine decarboxylase, in both wild‐type and *ΔsdaC* backgrounds (Table [A1](#mbo3960-tbl-0001){ref-type="table"}). In accordance with our hypothesis, *gcvP* deletion prevented lysis of the *ΔsdaC* strain (Figure [4](#mbo3960-fig-0004){ref-type="fig"}d). Notably, *ΔgcvP* strains exhibited a growth defect relative to wild‐type following glucose depletion (Figure [4](#mbo3960-fig-0004){ref-type="fig"}d), strengthening the notion that glycine cleavage is a major means of satisfying metabolic requirements when serine and glucose are absent.

3.5. The lysis phenotype is associated with a high serine to alanine ratio {#mbo3960-sec-0017}
--------------------------------------------------------------------------

We next sought to understand why production of serine through glycine cleavage might promote cell lysis upon glucose depletion. In bacteria, lysis is often indicative of a defect in cell wall biogenesis. A major component of the bacterial cell wall, peptidoglycan, is composed of glycan chains crosslinked by short peptides, and in *E. coli* and many other bacteria these peptide crosslinks have a high alanine content (Vollmer & Bertsche, [2008](#mbo3960-bib-0043){ref-type="ref"}). It was recently shown that serine can be misincorporated into peptidoglycan crosslinks in place of alanine (Parveen & Reddy, [2017](#mbo3960-bib-0030){ref-type="ref"}) when intracellular serine levels are high, likely due to weak substrate specificity of the enzyme that attaches L‐alanine to UDP‐N‐acetylmuramic acid in an early step of peptidoglycan biosynthesis (Liger, Blanot, & Heijenoort, [1991](#mbo3960-bib-0019){ref-type="ref"}). Misincorporation of serine reduced the rate of peptidoglycan production and sensitized cells to *β*‐lactam antibiotics (Parveen & Reddy, [2017](#mbo3960-bib-0030){ref-type="ref"}), indicating that it is deleterious. As a result, we hypothesized that lysis of the *ΔsdaC* strain could be due to a higher than normal serine to alanine ratio. Indeed, when we added 1.8 mM alanine to the lysis‐promoting growth medium (instead of the standard 0.8 mM in our AA‐rich medium), *ΔsdaC* cells no longer lysed (Figure [5](#mbo3960-fig-0005){ref-type="fig"}a). Strikingly, omission of alanine from the lysis‐promoting medium led to lysis of the wild‐type strain (Figure [5](#mbo3960-fig-0005){ref-type="fig"}b), further implicating a high serine to alanine ratio in triggering lysis upon glucose depletion. We also tested whether an orthogonal approach to altering alanine availability promotes lysis. Deletion of one of *E. coli*\'s three alanine‐synthesizing transaminases, *alaA* (Table [A1](#mbo3960-tbl-0001){ref-type="table"}), resulted in lysis of cells in which *sdaCB* was intact (Figure [5](#mbo3960-fig-0005){ref-type="fig"}c). Finally, addition of equimolar pyruvate to the lysis‐promoting medium was insufficient to prevent lysis of *ΔsdaC* cells, reinforcing the notion that lysis is not caused by a lack of serine deamination products (Figure [5](#mbo3960-fig-0005){ref-type="fig"}d).

![The lysis phenotype is associated with a high serine to alanine ratio. (a) Growth curves of wild‐type and *ΔsdaC* (*sdaC*::FRT, ecMK180) strains in AA‐rich medium with 1.4 mM glucose, no serine, and 1.8 mM alanine. (b) Growth curves of wild‐type and *ΔsdaC* (*sdaC*::FRT, ecMK180) strains in AA‐rich medium with 1.4 mM glucose, no serine, and no alanine. (c) Growth curves of wild‐type and *ΔalaA* (*alaA*::kan, ecMK165) strains in AA‐rich medium with 1.4 mM glucose, no serine, and 0.8 mM alanine. (d) Growth curves of wild‐type and *ΔsdaC* (*sdaC*::FRT, ecMK180) strains in AA‐rich medium with 1.4 mM glucose, no serine, 0.8 mM alanine, and 1.4 mM pyruvate. For all growth curves, three biological replicates are shown as points with their averages connected by lines](MBO3-9-e960-g005){#mbo3960-fig-0005}

4. DISCUSSION {#mbo3960-sec-0018}
=============

In this work, we discovered that glucose depletion in the absence of exogenous serine causes lysis of *E. coli* cells lacking the *sdaCB* operon. The lysis phenotype cannot be attributed to a requirement for serine deamination or its products, because (a) the lysis phenotype is independent of *sdaB* (Figure [3](#mbo3960-fig-0003){ref-type="fig"}a,b), (b) a mutant lacking all three serine deaminases does not lyse (Figure [A3](#mbo3960-fig-0008){ref-type="fig"}, panel b), and (c) exogenous pyruvate is unable to prevent lysis of *ΔsdaC* cells (Figure [5](#mbo3960-fig-0005){ref-type="fig"}d). Instead, we found SdaC to be the dominant activity in preventing lysis, thus revealing an unexpected role for serine transport during adaptation to changes in nutrient availability.

Lysis occurs upon glucose depletion in the absence of exogenously provided serine (Figure [2](#mbo3960-fig-0002){ref-type="fig"}a) and is promoted by glycine and the glycine cleavage system (Figure [4](#mbo3960-fig-0004){ref-type="fig"}). One possible explanation for these results is that exhaustion of primary serine sources (exogenous serine and its biosynthetic precursor, glucose) triggers catabolism of glycine (and possibly other amino acids) to satisfy cellular serine requirements and that this metabolic switch is surprisingly deleterious in the absence of *sdaC*. This scenario would suggest that serine produced via the GcvTHP/GlyA pathway has a greater potential to become toxic compared with serine synthesized de novo, possibly due to less stringent control of reaction rates leading to sudden accumulation of free serine. Indeed, we observed that *ΔserA* cells grown in glucose‐replete media do not appear to activate amino acid catabolic pathways upon exhaustion of exogenous serine, even though this should allow them to continue growing (Figure [1](#mbo3960-fig-0001){ref-type="fig"}e). Although this situation, which is presumably due to glucose‐mediated repression (Wonderling & Stauffer, [1999](#mbo3960-bib-0045){ref-type="ref"}), makes sense from an evolutionary perspective because wild‐type cells can produce serine from glucose (and amino acid precursors for producing serine are themselves useful as substrates for protein synthesis), our observation also implies that cells strongly prefer de novo synthesis to amino acid catabolism for endogenous production of serine.

In the above scenario, it is not immediately clear why SdaC can mitigate serine toxicity independent of SdaB. SdaC has been shown to import serine under physiological conditions (Hama, Shimamoto, Tsuda, & Tsuchiya, [1988](#mbo3960-bib-0011){ref-type="ref"}; Shao et al., [1994](#mbo3960-bib-0037){ref-type="ref"}), yet the medium that triggers lysis of *ΔsdaC* cells is devoid of exogenous serine. As a result, it might be that serine export is the function of SdaC that becomes essential upon glucose depletion. This notion is supported by our observations that (a) strong overexpression of the serine deaminase SdaB, which effectively removes serine from the cell, can compensate for loss of SdaC (Figure [3](#mbo3960-fig-0003){ref-type="fig"}b) and (b) *sdaC* expression reduces the growth yield of a serine auxotroph (Figure [3](#mbo3960-fig-0003){ref-type="fig"}d). SdaC is a proton/serine symporter that uses the energy gained from moving a proton down the electrochemical gradient (since cells are negative inside) to bring serine into the cell, often against its concentration gradient (Hama et al., [1988](#mbo3960-bib-0011){ref-type="ref"}; Shao et al., [1994](#mbo3960-bib-0037){ref-type="ref"}). However, because glucose depletion can reduce intracellular pH (Allison, Brynildsen, & Collins, [2011](#mbo3960-bib-0001){ref-type="ref"}; Orij, Postmus, Ter Beek, Brul, & Smits, [2009](#mbo3960-bib-0029){ref-type="ref"}; Peng et al., [2015](#mbo3960-bib-0031){ref-type="ref"}) and secondary transporters often operate near thermodynamic equilibrium (Konings, Poolman, & Veen, [1994](#mbo3960-bib-0016){ref-type="ref"}), it might be possible for glucose depletion to make the proton gradient favorable for serine export by SdaC, similar to the manner in which LacY reverses the direction of galactoside transport when the proton gradient is reduced (Guan & Kaback, [2009](#mbo3960-bib-0010){ref-type="ref"}). As with LacY, this reversal could either be active (coupled to movement of H^+^) or via passive exchange (no movement of H^+^) (Guan & Kaback, [2009](#mbo3960-bib-0010){ref-type="ref"}).

The other known serine transporters in *E. coli* are unlikely to export serine in the lysis‐promoting condition; the sodium‐serine symporter SstT would require a reversal of the sodium gradient and the anaerobic proton‐threonine/serine transporter TdcC is not expressed (Ogawa, Kim, Mizushima, & Tsuchiya, [1998](#mbo3960-bib-0028){ref-type="ref"}). An alternative possibility is that SdaC is required to scavenge serine released from dead cells and/or exported by another protein, but our results are not consistent with serine starvation being the cause of lysis. In particular, omission of glycine or addition of alanine are not expected to increase intracellular serine availability. SdaC could also possess an additional serine detoxification function independent of its serine transport activity, but we consider this possibility unlikely due to the high homology of SdaC to well‐defined amino acid transporters such as TdcC (Shao et al., [1994](#mbo3960-bib-0037){ref-type="ref"}).

Previous studies of *E. coli* lacking all three serine deaminases found that a triple mutant strain forms large, misshapen cells in glucose‐replete minimal media containing exogenous serine (Zhang et al., [2010](#mbo3960-bib-0047){ref-type="ref"}; Zhang & Newman, [2008](#mbo3960-bib-0048){ref-type="ref"}). These serine‐induced morphology defects occurred in the presence of *sdaC*, whereas we observe lysis of *ΔsdaC* cells but not *ΔsdaB ΔsdaA ΔtdcG* cells in our experimental condition (Figure [3](#mbo3960-fig-0003){ref-type="fig"}b). Moreover, we did not observe any morphological changes in the *sdaCB* strain upon glucose depletion; the only noticeable difference between mutant and wild‐type strains was cell size (Figure [2](#mbo3960-fig-0002){ref-type="fig"}c). Due to these significant differences in media composition and genetic determinants, it is unclear whether our lysis phenotype and the morphology defects observed by Zhang et al are related. In the case documented by Zhang et al, exogenous serine was responsible for the toxicity, whereas in our case endogenously produced serine may be the culprit. Interestingly, our observation that modulating alanine availability influences the lysis phenotype (Figure [5](#mbo3960-fig-0005){ref-type="fig"}) is consistent with Zhang et al\'s report that serine toxicity could be prevented by alanine supplementation or overexpression of the alanine ligase, MurC (Zhang et al., [2010](#mbo3960-bib-0047){ref-type="ref"}). Their hypothesis that free serine inhibits cell wall biogenesis by competing with alanine for MurC (Zhang et al., [2010](#mbo3960-bib-0047){ref-type="ref"}) was recently corroborated by HPLC analysis directly demonstrating incorporation of serine into peptidoglycan crosslinks at the position normally occupied by alanine when intracellular serine levels are high (Parveen & Reddy, [2017](#mbo3960-bib-0030){ref-type="ref"}). Serine incorporation was associated with a reduced rate of peptidoglycan production and sensitivity to *β*‐lactam antibiotics (Parveen & Reddy, [2017](#mbo3960-bib-0030){ref-type="ref"}), indicating that the presence of serine in peptidoglycan crosslinks is indeed deleterious. Thus, it is possible that in our experimental condition glucose depletion and subsequent production of serine from glycine might cause a sudden imbalance between free serine and alanine levels that leads to toxic incorporation of serine into the cell wall.

An additional possibility consistent with our results is that altered amino acid homeostasis caused by changing glycine and alanine concentrations or mutating *sdaC* affects intracellular signaling and/or gene expression in a manner that avoids lysis. We did observe that the *sdaCB* mutant consumed glucose faster than the wild‐type strain (Figure [2](#mbo3960-fig-0002){ref-type="fig"}f), so perhaps the cells have insufficient time to adapt to glucose depletion by synthesizing necessary biosynthetic enzymes. In this case, lysis might be caused by a shortage of enzymes and/or precursors needed for cell wall biogenesis. For example, expression of the major alanine racemase DadX, which catalyzes the production of D‐alanine from L‐alanine, is subject to catabolite repression in the presence of glucose (Wild, Hennig, Lobocka, Walczak, & Kłopotowski, [1985](#mbo3960-bib-0044){ref-type="ref"}).
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![*ΔsdaCB* growth defect is specific to glucose‐containing media. (a) Growth curves of wild‐type and serine deaminase single deletion strains (*sdaA::kan*, ecMK101; *sdaCB*::cm, ecMK102) grown in AA‐rich medium containing 5 mM serine and 0.5% (56 mM) glycerol or 0.5% (28 mM) glucose as the carbon source. (b) Growth curves of wild‐type and (*serA*::FRT, ecMK94) strains in AA‐rich medium (0.5% glucose) containing 5 mM serine. After 200 min of growth, serine was added to a final concentration of 5 mM to three wells for each strain (triangles). For all growth curves, three biological replicates are shown as points with their averages connected by lines](MBO3-9-e960-g006){#mbo3960-fig-0006}

![The lysis phenotype is specific to glucose depletion and also occurs in the MG1655 genetic background. (a) Growth curves of wild‐type and *ΔsdaCB* (*sdaCB*::cm, ecMK102) strains in AA‐rich medium containing 0.025% (1.4 mM) glucose and no serine (left), 1.4 mM glucose and 3 mM serine (center), or 5.6 mM glucose and no serine (right). Left panel is the same as in Figure [2](#mbo3960-fig-0002){ref-type="fig"}a and is shown for comparison. (b) Growth curves of MG1655 and MG1655 *ΔsdaCB* (*sdaCB*::cm, ecMK209) strains in AA‐rich medium containing 0.025% (1.4 mM) glucose and no serine. (c) Growth curves of wild‐type and *ΔsdaCB* (*sdaCB*::cm, ecMK102) strains in AA‐rich medium with no glucose or serine, but containing 0.025% (2.8 mM) glycerol or pyruvate. (d) Growth curves corresponding to the glucose measurements in Figure [2](#mbo3960-fig-0002){ref-type="fig"}e; wild‐type and *ΔsdaCB* (*sdaCB*::cm, ecMK102) strains in AA‐rich medium with no glucose and 1.4 mM serine. For all growth curves, three biological replicates are shown as points with their averages connected by lines](MBO3-9-e960-g007){#mbo3960-fig-0007}

![Expression levels of *sdaC* and *sdaB* in various mutant strains and lysis phenotypes of strains harboring different combinations of serine deaminase operon deletions and/or plasmids. (a) mRNA levels, as measured using qRT‐PCR, in indicated strains (from top to bottom: BW25113, ecMK163, 180, 102, 186, 188, 195) grown to midexponential phase in AA‐rich medium containing 5 mM serine. mRNA levels for *sdaC* and *sdaB* were normalized to the control gene *gapA*. ND = not detected, --RT = no reverse transcriptase. (b) Growth curves of strains harboring mutations in 0--3 of the serine deaminase loci (from top to bottom: BW25113, ecMK102, 228, 237, 236) in AA‐rich medium containing 0.025% (1.4 mM) glucose and no serine. (c) Growth curves of wild‐type and *ΔsdaCB* strains harboring plasmids expressing full‐length or truncated SdaC (premature stop codon at E83) in AA‐rich medium containing 0.025% (1.4 mM) glucose and no serine (ecMK136, 141, 221, 222). For growth curves, three biological replicates are shown as points with their averages connected by lines](MBO3-9-e960-g008){#mbo3960-fig-0008}

###### 

Strains and plasmids used in this study

  Strain/Plasmid                 Genotype                                                                                        Source
  ------------------------------ ----------------------------------------------------------------------------------------------- -----------------------------------------------------------------
  Wild‐type *Escherichia coli*   BW25113 (F‐, DE(araD‐araB)567, lacZ4787(del)::rrnB‐3, LAM‐, rph‐1, DE(rhaD‐rhaB)568, hsdR514)   Datsenko and Wanner ([2000](#mbo3960-bib-0006){ref-type="ref"})
  ecMK94                         BW25113 *serA*::FRT                                                                             This work
  ecMK101                        BW25113 *sdaA*::kan                                                                             This work
  ecMK102                        BW25113 *sdaCB*::cm                                                                             This work
  ecMK210                        BW25113 *tdcG*::cm                                                                              This work
  ecMK105                        BW25113 *serA*::FRT *sdaA*::kan                                                                 This work
  ecMK106                        BW25113 *serA*::FRT *sdaCB*::cm                                                                 This work
  ecMK211                        BW25113 *serA*::FRT *tdcG*::cm                                                                  This work
  ecMK136                        BW25113/pASEC1                                                                                  This work
  ecMK137                        BW25113/pMKEC24                                                                                 This work
  ecMK147                        BW25113/pMKEC32                                                                                 This work
  ecMK172                        BW25113/pMKEC35                                                                                 This work
  ecMK174                        BW25113/pMKEC36                                                                                 This work
  ecMK176                        BW25113/pMKEC37                                                                                 This work
  ecMK178                        BW25113/pMKEC30                                                                                 This work
  ecMK163                        BW25113 *sdaB*::kan                                                                             This work
  ecMK164                        BW25113 *serA*::FRT *sdaB*::kan                                                                 This work
  ecMK180                        BW25113 *sdaC*::FRT                                                                             This work
  ecMK181                        BW25113 *serA*::FRT *sdaC*::FRT                                                                 This work
  ecMK129                        BW25113 *gcvP*::kan                                                                             This work
  ecMK196                        BW25113 *sdaC*::FRT *gcvP*::cm                                                                  This work
  ecMK184                        BW25113/pMKEC38                                                                                 This work
  ecMK187                        BW25113/pMKEC39                                                                                 This work
  ecMK194                        BW25113/pMKEC41                                                                                 This work
  ecMK221                        BW25113/pMKEC43                                                                                 This work
  ecMK140                        BW25113 *serA*::FRT/pASEC1                                                                      This work
  ecMK197                        BW25113 *serA*::FRT/pMKEC38                                                                     This work
  ecMK200                        BW25113 *serA*::FRT/pMKEC41                                                                     This work
  ecMK142                        BW25113 *serA*::FRT *sdaCB*::cm/pASEC1                                                          This work
  ecMK198                        BW25113 *serA*::FRT *sdaCB*::cm/pMKEC38                                                         This work
  ecMK201                        BW25113 *serA*::FRT *sdaCB*::cm/pMKEC41                                                         This work
  ecMK141                        BW25113 *sdaCB*::cm/pASEC1                                                                      This work
  ecMK185                        BW25113 *sdaCB*::cm/pMKEC38                                                                     This work
  ecMK188                        BW25113 *sdaCB*::cm/pMKEC39                                                                     This work
  ecMK195                        BW25113 *sdaCB*::cm/pMKEC41                                                                     This work
  ecMK222                        BW25113 *sdaCB*::cm/pMKEC43                                                                     This work
  ecMK186                        BW25113 *sdaC*::FRT/pMKEC38                                                                     This work
  ecMK165                        BW25113 *alaA*::kan                                                                             This work
  ecMK236                        BW25113 *sdaB*::FRT *tdcG*::cm                                                                  This work
  ecMK237                        BW25113 *sdaB*::FRT *tdcG*::cm *sdaA*::kan                                                      This work
  ecMK228                        BW25113 *sdaCB*::FRT *tdcG*::cm *sdaA*::kan                                                     This work
  MG1655                         F‐, lambda‐, rph‐1                                                                              Blattner et al. ([1997](#mbo3960-bib-0003){ref-type="ref"})
  ecMK209                        MG1655 *sdaCB*::cm                                                                              This work
  pASEC1                         *SC101\* bla* PLtetO1 T7 RBS *yfp0*                                                             Subramaniam et al. ([2013](#mbo3960-bib-0042){ref-type="ref"})
  pMKEC24                        *SC101\* bla* PserA T7 RBS *yfp0*                                                               This work
  pMKEC30                        *SC101\* bla* PglyA T7 RBS *yfp0*                                                               This work
  pMKEC32                        *SC101\* bla* PsdaCB T7 RBS *yfp0*                                                              This work
  pMKEC35                        *SC101\* bla* Pkbl T7 RBS *yfp0*                                                                This work
  pMKEC36                        *SC101\* bla* PltaE T7 RBS *yfp0*                                                               This work
  pMKEC37                        *SC101\* bla* PgcvTHP T7 RBS *yfp0*                                                             This work
  pMKEC38                        *SC101\* bla* PsdaCB *sdaC*                                                                     This work
  pMKEC39                        *SC101\* bla* PLtetO1 T7 RBS *sdaB*                                                             This work
  pMKEC41                        *SC101\* bla* PsdaCB *sdaB*                                                                     This work
  pMKEC43                        *SC101\* bla* PsdaCB *sdaC* E83\*                                                               This work
  pKD13                          *oriR6K bla* FRT *kan* FRT                                                                      Datsenko and Wanner ([2000](#mbo3960-bib-0006){ref-type="ref"})
  pKD32                          *oriR6K bla* FRT *cat* FRT                                                                      Datsenko and Wanner ([2000](#mbo3960-bib-0006){ref-type="ref"})
  pSIM6                          *SC101\* repA^ts^ bla exo bet gam cI857^ts^*                                                    Datta et al. ([2006](#mbo3960-bib-0007){ref-type="ref"})
  pCP20                          *SC101\* repA^ts^ cI857^ts^ bla cat FLP*                                                        Datsenko and Wanner ([2000](#mbo3960-bib-0006){ref-type="ref"})
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###### 

Primers used in this study

+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| Primer    | Purpose                                                  | Sequence(5′--3′)                                                    |
+===========+==========================================================+=====================================================================+
| oMK175    | *tdcG*::cm deletion cassette generation (long homology)  | CAAGGCGATATGCGGTCTAC                                                |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK174    | *tdcG*::cm deletion cassette generation (long homology)  | GATGACCGTGTTTATCACCG                                                |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK173    | *sdaA*::kan deletion cassette generation (long homology) | GCGTGATTGGCGAATTGTAC                                                |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK172    | *sdaA*::kan deletion cassette generation (long homology) | GGCATAATTCGTGAGCTGGC                                                |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK169    | Making E83\* mutation in pMKEC38                         | GCCCGGGTTTTTACCAGACAGTACG                                           |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK168    | Making E83\* mutation in pMKEC38                         | CGTACTGTCTGGTAAAAACCCGGGCTAAGAC                                     |
|           |                                                          |                                                                     |
|           |                                                          | ATCACCGAGGTTGTAGAAG                                                 |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK163    | sdaC‐qRT‐rev                                             | TGCCATATCGCCGTACTCTT                                                |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK162    | sdaC‐qRT‐fwd                                             | CACTGGAAACGCTGTCTCTG                                                |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK161    | sdaB‐qRT‐rev                                             | CGGGTCACGTCTTTAAGCAG                                                |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK160    | sdaB‐qRT‐fwd                                             | ATTGGCCCTTCCAGTTCTCA                                                |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oAS‐P6‐3I | gapA‐qRT‐for                                             | GCTGAAGGCGAAATGAAAGG                                                |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oAS‐P6‐3J | gapA‐qRT‐rev                                             | GTACCAGGATACCAGTTTCACG                                              |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK159    | Cloning pMKEC41                                          | GGGATAATCTATCTTCCAAGTAGATTGTCCTT                                    |
|           |                                                          |                                                                     |
|           |                                                          | TCGCGCCGCTTTCGG                                                     |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK158    | Cloning pMKEC41                                          | AATCTACTTGGAAGATAGATTAT                                             |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK157    | Cloning pMKEC39                                          | ATTTGATGCCTCTAGACTCAGCTAATTAAGCT                                    |
|           |                                                          |                                                                     |
|           |                                                          | TTTAATCGCAGGCAACGATCTT                                              |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK156    | Cloning pMKEC38                                          | TTGTTTAACTTTAAGAAGGAGATGGTACCATG                                    |
|           |                                                          |                                                                     |
|           |                                                          | ATTAGCGTATTCGATATTTTC                                               |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK155    | Cloning pMKEC38                                          | ATTTGATGCCTCTAGACTCAGCTAATTAAGCT                                    |
|           |                                                          |                                                                     |
|           |                                                          | TTTAGCTGAACAGAGAGTAGAAG                                             |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK153    | Cloning pMKEC38                                          | GGCACCGGAGGCTTTCGTCTTCACCTCGAGG                                     |
|           |                                                          |                                                                     |
|           |                                                          | GTCACTTACTCATCAACTC                                                 |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK152    | Verification of chromosomal *sdaC* deletion              | GGTCCAACGGTATGAGAACT                                                |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK151    | *sdaC*::kan deletion cassette generation                 | CGGAGGAAGCGCCGCCCGAAAGCGGCGCGA AAGGACATTCCGGGGATCCGTCGACC           |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK148    | Cloning pMKEC36                                          | CCTTCTTAAAGTTAAACAAAATTATTGAATTCG                                   |
|           |                                                          |                                                                     |
|           |                                                          | GCATGTCCTTATTATGAC                                                  |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK147    | Cloning pMKEC36                                          | GGCACCGGAGGCTTTCGTCTTCACCTCGAGG                                     |
|           |                                                          |                                                                     |
|           |                                                          | ACGCGGTGATGAAGTGATC                                                 |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK146    | Cloning pMKEC35                                          | CCTTCTTAAAGTTAAACAAAATTATTGAATTCT                                   |
|           |                                                          |                                                                     |
|           |                                                          | GCGATTCTCCAGACAGGGC                                                 |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK145    | Cloning pMKEC35                                          | GGCACCGGAGGCTTTCGTCTTCACCTCGAGG                                     |
|           |                                                          |                                                                     |
|           |                                                          | TTTCCCTCCATTAGTGGGT                                                 |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK144    | Cloning pMKEC37                                          | CCTTCTTAAAGTTAAACAAAATTATTGAATTCC                                   |
|           |                                                          |                                                                     |
|           |                                                          | TTGTCCTCATTGAATAAGCGG                                               |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK143    | Cloning pMKEC37                                          | GGCACCGGAGGCTTTCGTCTTCACCTCGAGA                                     |
|           |                                                          |                                                                     |
|           |                                                          | AATTTCTCCTCTGTTGTTTATTTG                                            |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK134    | Verification of chromosomal *alaA* deletion              | GTTGCGCATGAGCGGCCAG                                                 |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK133    | Verification of chromosomal *alaA* deletion              | GCATGTAAAGCATATACACC                                                |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK132    | *alaA*::kan deletion cassette generation                 | CGCTGCCGGATGCAATCTCCGGCAGTGAAAT TAAGAATTCCGGGGATCCGTCGACC           |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK131    | *alaA*::kan deletion cassette generation                 | CGGCAGGGAGTGGCGATAACAGCAAAAAAG GTCAAGATTCGTGTAGGCTGGAGCTGCTTC       |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK130    | Verification of chromosomal *sdaB* deletion              | GCGATGATCCTGTTCCTGATG                                               |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK126    | Verification of chromosomal *serA* deletion              | GAAAGGCGGATGCAAATCC                                                 |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK125    | Verification of chromosomal *serA* deletion              | GACCTGCCCGTTGATTTTC                                                 |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK121    | Verification of chromosomal *gcvP* deletion              | CTGTCTGAGCACTTTTGTAC                                                |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK120    | Verification of chromosomal *gcvP* deletion              | GCATACGAAGCATTGTTAG                                                 |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK119    | *gcvP*::cm and *gcvP*::kan deletion cassette generation  | GTCATCTGACTAAAAAGGCGCCGAAGCGCCT                                     |
|           |                                                          |                                                                     |
|           |                                                          | TTAGAAAATTCCGGGGATCCGTCGACC                                         |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK118    | *gcvP*::cm and *gcvP*::kan deletion cassette generation  | GGTTCACAATTCACTGCACGTTTCAGGAACCA                                    |
|           |                                                          |                                                                     |
|           |                                                          | TCGCTCGTGTAGGCTGGAGCTGCTTC                                          |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK113    | Verification of chromosomal *tdcG* deletion              | CGCAGGAGAATATTCATTC                                                 |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK112    | Verification of chromosomal *tdcG* deletion              | GAAGCCATCGCAGTACGTAG                                                |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK111    | *tdcG*::cm deletion cassette generation                  | GCACATTTGTGCACCCAAGGATGAAAGCTGA CAGCAATGATTCCGGGGATCCGTCGACC        |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK110    | *tdcG*::cm deletion cassette generation                  | CCGCTCCACTTCACTGAACGGCAATCCGAGG GTGTGGATGTGTAGGCTGGAGCTGCTTC        |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK109    | Verification of chromosomal *sdaCB* deletion             | GATCAGGCGATAAGGGTAAC                                                |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK108    | Verification of chromosomal *sdaCB* deletion             | GATTAAGCCATCGCCGATAGAC                                              |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK107    | *sdaCB*::cm deletion cassette generation                 | CGGGAAGAGGCCTCGCAAAACGAGGCCTTT GGAGAGCGAATTCCGGGGATCCGTCGACC        |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK106    | *sdaCB*::cm deletion cassette generation                 | GCTAAAAGCTGAATTATTTGCATTCCTCCAGG AGAAATAGGTGTAGGCTGGAGCTGCTTC       |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK105    | Verification of chromosomal *sdaA* deletion              | GTAAGCGTATGGCGACAAAC                                                |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK104    | Verification of chromosomal *sdaA* deletion              | GTGAATAGTTAAGCCAGTCG                                                |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK103    | *sdaA*::kan deletion cassette generation                 | GGGTATAAATTCGCCCATCCGTTGCAGATGG GCGAGTAAGAAGTAATTCCGGGGATCCGTCG ACC |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK102    | *sdaA*::kan deletion cassette generation                 | CGTTACTGGAAGTCCAGTCACCTTGTCAGGA GTATTATCGTGTAGGCTGGAGCTGCTTC        |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK97     | Verification of kan^R^‐containing cassette integration   | GCGCATCGCCTTCTATCGCC                                                |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK86     | Cloning pMKEC32                                          | CCTTCTTAAAGTTAAACAAAATTATTGAATTCC                                   |
|           |                                                          |                                                                     |
|           |                                                          | TATTTCTCCTGGAGGAATGC                                                |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK84     | Cloning pMKEC30                                          | CCTTCTTAAAGTTAAACAAAATTATTGAATTCC                                   |
|           |                                                          |                                                                     |
|           |                                                          | CGCATCTCCTGACTCAGC                                                  |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK69     | Verification of cm^R^‐containing cassette integration    | GATCTTCCGTCACAGGTAGG                                                |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK68     | Verification of cm^R^‐containing cassette integration    | TTATACGCAAGGCGACAAGG                                                |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK66     | Verification of kan^R^‐containing cassette integration   | GGAACACGGCGGCATCAGAG                                                |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK49     | Cloning pMKEC24                                          | GGCACCGGAGGCTTTCGTCTTCACCTCGAGC                                     |
|           |                                                          |                                                                     |
|           |                                                          | GGTGTCAAAACCATTGTGAAATG                                             |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK48     | Cloning pMKEC24                                          | CCTTCTTAAAGTTAAACAAAATTATTGAATTCT                                   |
|           |                                                          |                                                                     |
|           |                                                          | TACCCAATCCTGTCTTTTGAAATG                                            |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK47     | Cloning into pZS11 backbone                              | GAATTCAATAATTTTGTTTAACTTTAAGAAGG                                    |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK39     | Sequence verification of transcriptional reporters       | GATCGTACGTTCTTGGAC                                                  |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK38     | Sequence verification of transcriptional reporters       | CAGGAAGGCAAAATGCCGC                                                 |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK37     | Cloning pMKEC32                                          | GGCACCGGAGGCTTTCGTCTTCACCTCGAGT                                     |
|           |                                                          |                                                                     |
|           |                                                          | CTCCGCTCCCCCGGTGACG                                                 |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK33     | Cloning pMKEC30                                          | GGCACCGGAGGCTTTCGTCTTCACCTCGAGA                                     |
|           |                                                          |                                                                     |
|           |                                                          | TGGTCTTCCTTTTTTTGCATC                                               |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMK27     | Cloning into pZS11 backbone                              | CTCGAGGTGAAGACGAAAGCCTCCGGTGCC                                      |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMF6      | Sequence verification of pZS11 plasmids                  | CAGTCTTTCGACTGAGCCTTTCGTTTTAT                                       |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
| oMF1      | Cloning into pZS11 backbone                              | GGTACCATCTCCTTCTTAAAGTTAAACAA                                       |
+-----------+----------------------------------------------------------+---------------------------------------------------------------------+
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